# European biotechnology innovation and funding gaps > Live situation record from CLSTR: https://clstr.news/situations/european-biotechnology-innovation-and-funding-gaps > Updated: 2026-10-14T08:11:35.000Z. Sources: 3. Developments: 2. The European and DACH (Germany, Austria, and Switzerland) biotechnology sectors are facing significant structural challenges regarding innovation, talent, and capital. Reports indicate a critical gap in the ability to translate scientific discoveries into commercially viable companies, often referred to as ‘Valleys of Death’. While the region maintains high academic and R&D standards, it struggles to scale compared to North America and China. A primary concern is the massive funding gap; European venture capital accounts for approximately 7 percent of the global life sciences market, whereas US-based funds hold 63 percent. Industry leaders have emphasized the necessity of long-term capital to support companies moving from research toward international expansion. Specific corporate setbacks have also been noted, such as BioNTech ending a Phase 2 oncology study due to a numerical imbalance in overall survival, alongside declining revenues and revised sales forecasts. ## Timeline ### 2026-10-14: DACH region life sciences sector faces translation and funding gaps Industry leaders highlight the need to bridge the gap between scientific research and commercial success in the DACH region's life sciences sector to compete with North America and China. 2 sources. https://clstr.news/cluster/dach-region-life-sciences-sector-faces-translation-and-funding-gaps ### 2026-10-09: European biotechnology sector faces structural funding and innovation gaps A report by ESMT Berlin warns of a critical structural deficit in Europe's biotech sector, citing funding gaps and poor technology transfer, as companies like BioNTech face clinical and financial transitions. 2 sources. https://clstr.news/cluster/european-biotechnology-sector-faces-structural-funding-and-innovation-gaps --- Cite as: European biotechnology innovation and funding gaps. CLSTR, https://clstr.news/situations/european-biotechnology-innovation-and-funding-gaps